| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.4 | 9e-27 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |